|
1
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–55. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Blum HE: Hepatocellular carcinoma: Therapy
and prevention. World J Gastroenterol. 11:7391–7400.
2005.PubMed/NCBI
|
|
3
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thorgeirsson SS and Grisham JW: Molecular
pathogenesis of human hepatocellular carcinoma. Nat Genet.
31:339–346. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rapado-González Ó, Majem B, Muinelo-Romay
L, Álvarez-Castro A, Santamaría A, Gil-Moreno A, López-López R and
Suárez-Cunqueiro MM: Human salivary microRNAs in Cancer. J Cancer.
9:638–649. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hosseinahli N, Aghapour M, Duijf PHG and
Baradaran B: Treating cancer with microRNA replacement therapy: A
literature review. J Cell Physiol. 233:5574–5588. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma J and Li X: MicroRNAs are involved in
the toxicity of microcystins. Toxin Reviews. 36:165–175. 2017.
View Article : Google Scholar
|
|
11
|
Ma J, Li Y, Yao L and Li X: Analysis of
microRNA expression profiling involved in MC-LR-induced
cytotoxicity by high-throughput sequencing. Toxins (Basel). 9(pii):
E232017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chakraborty C, Sharma AR, Sharma G, Sarkar
BK and Lee SS: The novel strategies for next-generation cancer
treatment: miRNA combined with chemotherapeutic agents for the
treatment of cancer. Oncotarget. 9:10164–10174. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vannini I, Fanini F and Fabbri M: Emerging
roles of microRNAs in cancer. Curr Opin Genet Dev. 48:128–133.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lou W, Liu J, Gao Y, Zhong G, Chen D, Shen
J, Bao C, Xu L, Pan J, Cheng J, et al: MicroRNAs in cancer
metastasis and angiogenesis. Oncotarget. 8:115787–115802. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin Y, Xu T, Zhou S and Cui M:
MicroRNA-363 inhibits ovarian cancer progression by inhibiting
NOB1. Oncotarget. 8:101649–101658. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song B, Yan J, Liu C, Zhou H and Zheng Y:
Tumor Suppressor Role of miR-363-3p in Gastric Cancer. Med Sci
Monit. 21:4074–4080. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ying J, Yu X, Ma C, Zhang Y and Dong J:
MicroRNA-363-3p is downregulated in hepatocellular carcinoma and
inhibits tumorigenesis by directly targeting specificity protein 1.
Mol Med Rep. 16:1603–1611. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y, Chen T, Huang H, Jiang Y, Yang L,
Lin Z, He H, Liu T, Wu B, Chen J, et al: miR-363-3p inhibits tumor
growth by targeting PCNA in lung adenocarcinoma. Oncotarget.
8:20133–20144. 2017.PubMed/NCBI
|
|
19
|
Hu F, Min J, Cao X, Liu L, Ge Z, Hu J and
Li X: MiR-363-3p inhibits the epithelial-to-mesenchymal transition
and suppresses metastasis in colorectal cancer by targeting Sox4.
Biochem Biophys Res Commun. 474:35–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Han H, Sun D, Li W, Shen H, Zhu Y, Li C,
Chen Y, Lu L, Li W, Zhang J, et al: A c-Myc-MicroRNA functional
feedback loop affects hepatocarcinogenesis. Hepatology.
57:2378–2389. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao X, Dai M, Li Q, Wang Z, Lu Y and Song
Z: HMGA2 regulates lung cancer proliferation and metastasis. Thorac
Cancer. 8:501–510. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang W, Li J, Guo X, Zhao Y and Yuan X:
miR-663a inhibits hepatocellular carcinoma cell proliferation and
invasion by targeting HMGA2. Biomed Pharmacother. 81:431–438. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pallante P, Sepe R, Puca F and Fusco A:
High mobility group a proteins as tumor markers. Front Med
(Lausanne). 2:152015.PubMed/NCBI
|
